Skip to content

Goodwill at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$9.12B+3.1%
HRO
HarrowHROW
$332K0.0%
Precigen logo
PrecigenPGEN
$15.23M-20.4%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$44M-0.9%
Abbott logo
AbbottABT
$35.22B+50.8%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$593.8M-0.6%

Segments

By segment

See full
Diagnostics$163.44M0.0%

By geography

See full
IE$89.5M

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B-22.4%
P/S1.9×-0.2×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×
Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's goodwill?
Opko Health (OPK) reported goodwill of $482.27M in Q1 2026.
How has Opko Health's goodwill changed year-over-year?
Opko Health's goodwill increased by 1.2% year-over-year, from $476.67M to $482.27M.
What is the long-term trend for Opko Health's goodwill?
Over 5 years (2020 to 2025), Opko Health's goodwill has grown at a -7.6% compound annual growth rate (CAGR), from $718.63M to $484.29M.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.